Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-2-2
pubmed:abstractText
Immunotherapy is the only effective method of treatment of allergy to Hymenoptera venom. Pretreatment with antihistamines diminishes the incidence of adverse reactions (AR) such as large local and mild systemic reactions but it is suggested that it may mask a development of serious allergic reactions. The aim of the study was a retrospective evaluation of the incidence and nature of AR during venom immunotherapy in patients receiving pretreatment with antihistamines in the Department of Pneumonology and Allergy of the Medical University of Lodz. RESULTS: 50 patients started "ultra-rush" immunotherapy in our center, 8 were taken in our care after the initiation phase had been conducted elsewhere. During the dose increase phase 10 systemic adverse reactions were observed. 50% of them were only subjective and the rest mild objective reactions. During the maintenance phase 10 systemic reactions were noted, among them 2 cases of the anaphylactic shock. The incidence of systemic adverse reactions was 1 per 86 injections. Late as well as unusual reactions appeared twice. CONCLUSIONS: Venom immunotherapy combined with pretreatment with antihistamines is safe. A vast majority of systemic adverse reactions is of subjective and mild objective nature and appropriate treatment leads to containment of severe reactions.
pubmed:language
pol
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0867-7077
pubmed:author
pubmed:issnType
Print
pubmed:volume
74
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
153-8
pubmed:meshHeading
pubmed-meshheading:17269362-Adolescent, pubmed-meshheading:17269362-Adult, pubmed-meshheading:17269362-Aged, pubmed-meshheading:17269362-Anaphylaxis, pubmed-meshheading:17269362-Animals, pubmed-meshheading:17269362-Bee Venoms, pubmed-meshheading:17269362-Desensitization, Immunologic, pubmed-meshheading:17269362-Erythema, pubmed-meshheading:17269362-Female, pubmed-meshheading:17269362-Histamine Antagonists, pubmed-meshheading:17269362-Humans, pubmed-meshheading:17269362-Hypersensitivity, Immediate, pubmed-meshheading:17269362-Male, pubmed-meshheading:17269362-Middle Aged, pubmed-meshheading:17269362-Premedication, pubmed-meshheading:17269362-Pruritus, pubmed-meshheading:17269362-Ranitidine, pubmed-meshheading:17269362-Retrospective Studies, pubmed-meshheading:17269362-Terfenadine, pubmed-meshheading:17269362-Treatment Outcome, pubmed-meshheading:17269362-Wasp Venoms
pubmed:year
2006
pubmed:articleTitle
[Safety of venom immunotherapy in patients pretreated with antihistamines--a retrospective study].
pubmed:affiliation
Z Kliniki Chorób Wewnetrznych, Astmy i Alergii Katedry Pulmonologii i Alergologii Uniwersytetu Medycznego, ?odzi. dtworek@poczta.onet.pl
pubmed:publicationType
Journal Article, English Abstract